» Authors » Hirokazu Urushiyama

Hirokazu Urushiyama

Explore the profile of Hirokazu Urushiyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 329
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Okabe Y, Toda E, Urushiyama H, Terashima Y, Kunugi S, Kajimoto Y, et al.
Sci Rep . 2024 Oct; 14(1):23653. PMID: 39384840
The accumulation of monocyte-derived macrophages in the lung tissue during inflammation is important for the pathogenesis of fibrotic lung disease. Deficiencies in chemokine receptors CCR2 and CCR5 and their ligands,...
2.
Saihara-Yamaguchi A, Urushiyama H, Makita K, Aso S, Watanabe H, Yokoyama A, et al.
Respir Investig . 2024 Sep; 62(6):1053-1057. PMID: 39303571
Background: Shoseiryuto, a Japanese herbal medicine, is used to treat asthma exacerbation; however, the effect of Shoseiryuto in a clinical setting is yet to be elucidated. We aimed to examine...
3.
Awano N, Jo T, Izumo T, Urushiyama H, Matsui H, Fushimi K, et al.
Respir Investig . 2024 Jul; 62(5):844-849. PMID: 39053074
Background: Transbronchial lung cryobiopsy (TBLC) is a new technique for obtaining high-quality and large-sized lung tissues, as compared to transbronchial forceps biopsy (TBFB), and is useful in the diagnosis of...
4.
Enokido T, Hiraishi Y, Jo T, Urushiyama H, Saito A, Noguchi S, et al.
Respir Investig . 2024 May; 62(4):599-605. PMID: 38696950
Background: The association between reflux esophagitis and pulmonary function remains controversial. Thus, evaluating the relationship between endoscopic reflux esophagitis and changes in pulmonary function over time in a nonsmoking population...
5.
Yoshiyasu N, Matsuki R, Sato M, Urushiyama H, Toda E, Terasaki Y, et al.
Transpl Int . 2024 Apr; 37:12556. PMID: 38650846
Macrophages contribute to post-transplant lung rejection. Disulfiram (DSF), an anti-alcoholic drug, has an anti-inflammatory effect and regulates macrophage chemotactic activity. Here, we investigated DSF efficacy in suppressing acute rejection post-lung...
6.
Awano N, Jo T, Izumo T, Inomata M, Morita K, Matsui H, et al.
Ann Clin Epidemiol . 2024 Mar; 5(2):37-47. PMID: 38505731
Background: Acute exacerbation of idiopathic interstitial pneumonias (AE-IIPs) has a high mortality. However, there is no established treatment for AE-IIPs. Therefore, we aimed to compare the efficacy of high- and...
7.
Awano N, Jo T, Izumo T, Inomata M, Ito Y, Morita K, et al.
J Intensive Care . 2023 Oct; 11(1):45. PMID: 37821999
Background: The prognosis for acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is poor, and there is no established treatment. Hence, we aimed to investigate the effectiveness of a polymyxin B-immobilised...
8.
Yokoyama A, Jo T, Sakamoto Y, Urushiyama H, Tamiya H, Tanaka G, et al.
Geriatr Gerontol Int . 2023 Oct; 23(11):849-854. PMID: 37804182
Aim: Behavioral and psychological symptoms and delirium frequently occur in hospitalized older patients with pneumonia and are associated with longer hospital stays. Yokukan-San (YKS, traditional Japanese [Kampo] medicine) and antipsychotics...
9.
Awano N, Jo T, Izumo T, Inomata M, Ito Y, Hashimoto Y, et al.
Respir Investig . 2023 Sep; 61(6):720-728. PMID: 37714090
Background: Interstitial lung diseases (ILDs) are a group of diffuse parenchymal lung disorders that cause inflammation and fibrosis in the interstitium of the lungs. Histopathological examination is pivotal to accurately...
10.
Jo T, Shigemi D, Konishi T, Yamana H, Michihata N, Kumazawa R, et al.
Intern Med . 2023 Jul; 63(7):919-927. PMID: 37495535
Objective The effect of Rikkunshito, a Japanese herbal Kampo medicine, on chemotherapy-induced nausea and vomiting (CINV) has been evaluated in several small prospective studies, with mixed results. We retrospectively evaluated...